Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Bassem Zarif

2PUBLICATIONS

24CO-AUTHORS

Cardiology (incl. cardiovascular diseases)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Aug 28, 2025

Effect of Pharmacogenetics on Renal Outcomes of Heart Failure Patients with Reduced Ejection Fraction (HFrEF) in Response to Dapagliflozin.

Neven Sarhan, Mona F Schaalan, Azza A K El-Sheikh

|Oct 25, 2024

ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation.

Mohamed Sobhy, Adel Eletriby, Hany Ragy

Pageof 1

Frequent Collaborators

1 joint publications

Hany Ragy

1 joint publications

Hossam Kandil

1 joint publications

Mohamed Ayman Saleh

1 joint publications

Ahmed Bendary

1 joint publications

Ahmed Shawky

1 joint publications

Ayman Khairy

1 joint publications

Ayman Mortada

1 joint publications

Haitham Badran

1 joint publications

Hazem Khorshid

1 joint publications

Kareem Mahmoud

Frequent Collaborators

1 joint publications

Hany Ragy

1 joint publications

Hossam Kandil

1 joint publications

Mohamed Ayman Saleh

1 joint publications

Ahmed Bendary

Top Related Videos

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on : May 26, 2022

See more related videos

Top Related Videos

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on : May 26, 2022

See more related videos